IGAN
Clinical trials for IGAN explained in plain language.
Never miss a new study
Get alerted when new IGAN trials appear
Sign up with your email to follow new studies for IGAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney disease: experimental drug aims to reduce protein leak
Disease control Not yet recruitingThis study tests an experimental drug called FXS6837 in about 60 adults with IgA nephropathy, a kidney disease that can lead to kidney failure. Participants will receive either the drug or a placebo for 6 months to see if it lowers protein levels in urine, a sign of kidney damage…
Matched conditions: IGAN
Phase: PHASE2 • Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New pill aims to slow kidney disease in IgA nephropathy patients
Disease control Not yet recruitingThis study tests a new drug, HS-10542, in 90 adults with IgA nephropathy, a kidney disease. The goal is to see if it can lower protein in the urine, a sign of kidney damage. Participants will take either the drug or a placebo for a set period, and researchers will monitor safety …
Matched conditions: IGAN
Phase: PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:47 UTC